copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Homepage - Staar Surgical STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems
Contact Us - Staar Surgical The STAAR Surgical Company customer service department in Monrovia, California, is available to assist you Monday through Friday, from 6:00 a m to 5:00 p m PST by calling 800-352-7842
STAAR Surgical Company - Home STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses
STAAR Surgical Company -- Company History STAAR Surgical Company (Staar) develops and markets medical devices for use in refractive, cataract, and glaucoma surgery Staar's principal products include foldable intraocular lenses and implantable contact lenses
Staar Surgical Reappoints Company Vet Deborah Andrews as CFO Staar Surgical said Wednesday that it has appointed Deborah Andrews as its chief financial officer again, marking her return to the company after her retirement five years ago Andrews retired
STAAR Surgical Company (STAA) Company Profile Description STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye
Our Mission - Staar Surgical STAAR has been dedicated solely to ophthalmic surgery for over 40 years STAAR has over 900 full-time equivalent employees and markets lenses in over 75 countries STAAR® developed, patented, and licensed the first foldable intraocular lens, or IOL, for cataract surgery
STAAR Surgical Company - STAAR Surgical Announces Appointment . . . STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that Deborah Andrews has been appointed Chief Financial Officer, effective June 25, 2025 Ms Andrews has served as Interim CFO since March 2025, and she previously served as STAAR’s CFO from 2007-2013 and 2017-2020